Skip to main content

Senate bill · S. 5265 (119th Congress)

Identify and take action against international trade practices of high income countries that unfairly exploit innovation by deviating from market-based…

U.S. Senate

Latest action Aug 5, 2026

Sponsor: Tim Sheehy (U.S. Senator for Montana, Republican)

Official titleShow

A bill to identify and take action against international trade practices of high income countries that unfairly exploit innovation by deviating from market-based policies and unfairly exploit United States innovation, and for other purposes.

The heading above is this same sentence with its legal opening removed. No words were added, changed or reordered.

Follow

Following needs an Agora account. You will sign in first, then come back to this page.

From Congress.gov and official rosters. This record was last updated Oct 8, 2026. About our data

Summary

Use Sovereignty To reduce Rx Act or the USTRx Act This bill establishes the role of Chief Pharmaceutical Trade Negotiator within the Office of the U.S. Trade Representative (USTR). The negotiator must conduct trade negotiations, enforce trade agreements relating to U.S. pharmaceutical products, and address acts, policies, or practices of high-income countries that adversely impact the market access of U.S. pharmaceutical manufacturers. The USTR must annually compile a list of high-income countries based on official statistics of the International Bank for Reconstruction and Development of the World Bank. Based on that list, the negotiator must submit a report describing (1) such countries' actions and impacts relating to the pharmaceutical trade, and (2) the current status of any responsive actions taken by the United States. The bill also requires the USTR to submit to Congress a plan to respond to certain adverse acts, policies, or practices of high-income countries that are related to the trade of pharmaceutical products.

Summary from the Congressional Research Service. How we handle summaries

Where it stands

Assigned to a committee for review.

  1. Introduced
  2. In committee
  3. Up for a vote
  4. Passed one chamber
  5. Passed
  6. Enacted

Committee

Senate Committee on Finance · U.S. Senate

Your position on this bill

Choose the position closest to yours. You'll sign in or create an account to save it.

Cosponsors

Showing the cosponsors who are on Agora, A to Z. The official record may list more.

Read on Congress.gov (opens in a new tab)
  • Republican1

Shown in neutral colors by design; Agora is non-partisan.

Full history

  1. Aug 5, 2026

    Introduced

    Introduced in U.S. Senate

    U.S. Senate

  2. Aug 5, 2026

    Referred to committee

    Read twice and referred to the Committee on Finance.

  3. Aug 5, 2026

    Referred to committee

    Read twice and referred to the Committee on Finance.

Read the record